Literature DB >> 3785188

Template requirements for in vivo replication of adenovirus DNA.

J A Bernstein, J M Porter, M D Challberg.   

Abstract

The adenovirus (Ad) DNA origin of replication was defined through an analysis of the DNA sequences necessary for the replication of plasmid DNAs with purified viral and cellular proteins. Results from several laboratories have shown that the origin consists of two functionally distinct domains: a 10-base-pair sequence present in the inverted terminal repetition (ITR) of all human serotypes and an adjacent sequence constituting the binding site for a cellular protein, nuclear factor I. To determine whether the same nucleotide sequences are necessary for origin function in vivo, we developed an assay for the replication of plasmid DNAs transfected into Ad5-infected cells. The assay is similar to that described by Hay et al. (J. Mol. Biol. 175:493-510, 1984). With this assay, plasmid DNA replication is dependent upon prior infection of cells with virus and only occurs with linear DNA molecules containing viral terminal sequences at each end. Replicated DNA is resistant to digestion with lambda-exonuclease, suggesting that a protein is covalently bound at both termini. A plasmid containing only the first 67 base pairs of the Ad2 ITR replicates as well as plasmids containing the entire ITR. Deletions or point mutations which reduce the binding of nuclear factor I to DNA in vitro reduce the efficiency of plasmid replication in vivo. A point mutation within the 10-base-pair conserved sequence has a similar effect upon replication. These results suggest that the two sequence domains of the Ad origin identified by in vitro studies are in fact important for viral DNA replication in infected cells. In addition, we found that two separate point mutations which lie outside these two sequence domains, and which have little or no effect upon DNA replication in vitro, also reduce the apparent efficiency of plasmid replication in vivo. Thus, there may be elements of the Ad DNA origin of replication which have not yet been identified by in vitro studies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3785188      PMCID: PMC367752          DOI: 10.1128/mcb.6.6.2115-2124.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

1.  Adenovirus sequences required for replication in vivo.

Authors:  K Wang; G D Pearson
Journal:  Nucleic Acids Res       Date:  1985-07-25       Impact factor: 16.971

2.  A unique form of terminal redundancy in adenovirus DNA molecules.

Authors:  C F Garon; K W Berry; J A Rose
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

3.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

4.  Properties of a supercoiled deoxyribonucleic acid-protein relaxation complex and strand specificity of the relaxation event.

Authors:  D B Clewell; D R Helinski
Journal:  Biochemistry       Date:  1970-10-27       Impact factor: 3.162

5.  Isolation of DNA replication complexes from uninfected and adenovirus-infected HeLa cells.

Authors:  G D Pearson; P C Hanawalt
Journal:  J Mol Biol       Date:  1971-11-28       Impact factor: 5.469

6.  Adenovirus DNA replication in vitro: identification of a host factor that stimulates synthesis of the preterminal protein-dCMP complex.

Authors:  K Nagata; R A Guggenheimer; T Enomoto; J H Lichy; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

7.  Purification of an adenovirus-coded DNA polymerase that is required for initiation of DNA replication.

Authors:  B W Stillman; F Tamanoi; M B Mathews
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

8.  Separation of the adenovirus terminal protein precursor from its associated DNA polymerase: role of both proteins in the initiation of adenovirus DNA replication.

Authors:  J H Lichy; J Field; M S Horwitz; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

9.  Effects of the adenovirus H5ts125 and H5ts107 DNA binding proteins on DNA replication in vitro.

Authors:  B R Friefeld; M D Krevolin; M S Horwitz
Journal:  Virology       Date:  1983-01-30       Impact factor: 3.616

10.  The infectivity of adenovirus genomes lacking DNA sequences from their left-hand termini.

Authors:  N D Stow
Journal:  Nucleic Acids Res       Date:  1982-09-11       Impact factor: 16.971

View more
  7 in total

1.  The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells.

Authors:  Jianhong Hu; Alexander C Garber; Rolf Renne
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

Review 2.  The MRE11-RAD50-NBS1 Complex Conducts the Orchestration of Damage Signaling and Outcomes to Stress in DNA Replication and Repair.

Authors:  Aleem Syed; John A Tainer
Journal:  Annu Rev Biochem       Date:  2018-04-25       Impact factor: 23.643

3.  Sequence and structural requirements of a herpes simplex viral DNA replication origin.

Authors:  D Lockshon; D A Galloway
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

4.  Cotransfection with adenovirus DNA enhances transcription from linear DNA containing eucaryotic promoters.

Authors:  M B Vasudevachari; V Natarajan; N P Salzman
Journal:  Mol Cell Biol       Date:  1987-03       Impact factor: 4.272

5.  Deletion of the E4 region of the genome produces adenovirus DNA concatemers.

Authors:  M D Weiden; H S Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

6.  Role for the adenovirus IVa2 protein in packaging of viral DNA.

Authors:  W Zhang; J A Low; J B Christensen; M J Imperiale
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

7.  Nuclear factor I enhances adenovirus DNA replication by increasing the stability of a preinitiation complex.

Authors:  Y M Mul; P C Van der Vliet
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.